63539-927 : Lorbrena 25 mg Oral Tablet, Film Coated


NDC: 63539-927
Labeler: U.S. Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Lorbrena
Dosage Form: Oral Tablet, Film Coated
Application #: NDA210868
Rev. Date: 


NDC Package Codes:

  • 63539-927-01: 30 TABLET, FILM COATED IN 1 BOTTLE (63539‑927‑01)

Active Ingredients:

  • Lorlatinib

Dosage Strength:

  • 25 mg

Pharmaceutical Classes:

  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]
  • Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
  • Organic Anion Transporter 3 Inhibitors [MoA]
  • Organic Cation Transporter 1 Inhibitors [MoA]
  • P-Glycoprotein Inducers [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0227 Lorbrena 25 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
  • 0069-0231 Lorbrena 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63539-927 QR Code

< Prev: 63539-688Next: 63545-001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.